4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-021522
CHIEF FINANCIAL OFFICER sold 8,000 shares
- CHIEF FINANCIAL OFFICER acquired 2,954 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | 2025-08-11 | Sale | −8,000 | 28,236 | D | ||
| BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | 2025-08-12 | Option exercise | +2,954 | $26.49 | $78,251 | 31,190 | D |
| Derivatives | |||||||
| BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | 2025-08-12 | Option exercise · Employee Stock Option (right to buy) | −2,954 | 29,046 | D | ||
| Open-market sales · 8,000 sh | |||||||
Loading xslF345X05/form4-08122025_110857.xml…